ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations

…, T Bradbury, G Brusselle, C Cadus… - European …, 2022 - Eur Respiratory Soc
Clinical trials evaluating the management of acute exacerbations of COPD assess heterogeneous
outcomes, often omitting those that are clinically relevant or more important to patients…

[HTML][HTML] Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocol

…, A Bikov, T Bradbury, G Brusselle, C Cadus… - ERJ open …, 2020 - Eur Respiratory Soc
Randomised controlled trials (RCTs) on the management of COPD exacerbations evaluate
heterogeneous outcomes, often omitting those that are clinically important and patient …

Adherence to GOLD recommendations among Swiss pulmonologists and general practitioners

JL Marmy, JP Diedrich, C Cadus… - COPD: Journal of …, 2020 - Taylor & Francis
Significant variability in adherence to COPD management recommendations has been
reported. We aimed to evaluate real-life COPD pharmacotherapy prescribing patterns and …

Inhalative Therapie bei COPD und Asthma

…, P Grendelmeier, C Cadus - Therapeutische …, 2019 - econtent.hogrefe.com
Die inhalative Therapie ist nach wie vor sowohl bei der COPD als auch beim Asthma eine
wichtige Säule der Behandlung. Bei Asthma Patienten stehen primär die inhalativen …

Development of inhaled therapies for COPD and asthma

…, A Tschacher, P Grendelmeier, C Cadus - Therapeutische …, 2019 - europepmc.org
Development of inhaled therapies for COPD and asthma Abstract. Inhaled therapies still
represent one of the most important pillars of the COPD and asthma treatments. In recent years, …

Seltene Komplikation einer häufigen Erkrankung: Schilddrüse und epileptische Anfälle

C Cadus, A Mehlig, A Minder - Praxis, 2018 - econtent.hogrefe.com
Die Myxödemkrise ist eine lebensbedrohliche Komplikation einer nicht oder unzureichend
behandelten Hypothyreose (Mortalität 20–25%). Die Diagnosestellung erfolgt anhand der …

Switching COPD patients from the disposable to the new reusable Respimat soft mist inhaler: a real-world study from Switzerland

A Tschacher, C Cadus, S Schildge… - Current Medical …, 2021 - Taylor & Francis
Objective The aims of the survey were to assess first experiences of Swiss COPD patients
switching from the disposable to the new reusable Respimat inhaler, and to evaluate …

Predictors for treatment changes in COPD–A Swiss Cohort Study

…, NA Hussein, PO Bridevaux, C Cadus… - 2020 - Eur Respiratory Soc
Introduction: Chronic obstructive pulmonary disease (COPD) is a widely spread chronic
disease. In Switzerland, it is estimated that 400’000 patients suffer from COPD and 65million …

Rare Complication of a Common Disease: Thyroid and Epileptic Seizures

C Cadus, A Mehlig, A Minder - Praxis, 2018 - europepmc.org
Rare Complication of a Common Disease: Thyroid and Epileptic Seizures Abstract. A
myxedema crisis is a life-threatening complication of hypothyroidism (mortality 20-25%). The …

[CITATION][C] Halbautomatisierte computerunterstützte Segmentierung von Tumoren des Kopf-Hals-Bereiches: eine genaue und zeitsparende Methode zur …

CF Cadus - 2015 - Johann Wolfgang-Goethe …